天通股份(600330.SH):天通吉成中標108單晶項目主設備採購項目
格隆匯12月28日丨天通股份(600330.SH)公佈,2020年12月28日,天通控股股份有限公司全資子公司天通吉成機器技術有限公司(以下簡稱“天通吉成”)收到了江蘇緯承招標有限公司發來的《中標通知書》,確認天通吉成為江蘇協鑫硅材料科技發展有限公司108單晶項目主設備採購中標單位,中標總價為6.27億元人民幣(含税)。項目的中標進一步提升了公司在光伏太陽能硅片製造設備領域中的行業地位,對天通硅片設備的快速發展具有重要意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.